Yulia’s expertise lies in the areas of materials engineering with specialism in biomedical and pharmaceutical engineering. She specialises in various aspects of materials manufacturing and technology with a particular emphasis on medical devices.
Yulia obtained her Masters (Hons) Degree in Chemistry from Tula State University, Russia in 2005.
She then worked for the Russian Police Force as a forensic expert/crime scene investigator, specialising in forensic analytical chemistry. In 2009 she moved to the UK to undertake her PhD in the chemistry of materials for the manufacturing of fine chemicals and commodities, which she completed in 2012.
In 2013-17 she worked as a Postdoctoral Researcher at the Universities of Sheffield and Bradford where she focused on managing a number of projects in the areas of biomedical and pharmaceutical engineering. Having worked in collaboration with several SMEs from both the UK and EU as part of her research activities, she used her experience and knowledge in the area of materials engineering and technology for orthopaedics and drug delivery systems to bridge the gap between industries and academia. She is an Associate Fellow of the Higher Education Academy since July 2016.
Yulia joined HGF in January 2018 as a Trainee Patent Attorney in the Sheffield office where she is currently working towards her qualification as a Patent Attorney.
Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …Read article
Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder . …Read article
Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …Read article
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …Read article
After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …Event details
HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …Event details
HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.